NYSE:CRD.B • US2246331076
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CRAWFORD & CO -CL B (CRD.B).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-07 | Truist Securities | Maintains | Buy -> Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.231B 8.08% | 1.317B 6.96% | 1.341B 1.83% | 1.352B 0.82% | 1.44B 6.51% | 1.495B 3.82% | |
| EBITDA YoY % growth | 88.263M -2.58% | 100.135M 13.45% | 94.169M -5.96% | 128.69M 36.66% | 139.73M 8.58% | 153.45M 9.82% | |
| EBIT YoY % growth | 52.165M 3.45% | 64.393M 23.44% | 57.974M -9.97% | 86.826M 49.77% | 101.89M 17.35% | 115.99M 13.84% | |
| Operating Margin | 4.24% | 4.89% | 4.32% | 6.42% | 7.08% | 7.76% | |
| EPS YoY % growth | 0.70 -4.11% | 0.93 32.86% | 0.79 -15.05% | 1.01 13.92% | 1.12 24.36% | 1.19 6.75% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.26 22.62% | 0.28 28.75% | 0.30 -5.05% | 0.30 102.57% | 0.28 8.00% | 0.30 5.45% | 0.30 -1.69% | 0.31 1.69% |
| Revenue Q2Q % growth | 349.52M 12.01% | 361.88M 12.04% | 360.65M 11.94% | 375.27M 21.64% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
11 analysts have analysed CRD.B and the average price target is 14.28 USD. This implies a price increase of 36.65% is expected in the next year compared to the current price of 10.45.
CRAWFORD & CO -CL B (CRD.B) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of CRAWFORD & CO -CL B (CRD.B) is 0.26 USD and the consensus revenue estimate is 349.52M USD.